CAMBRIDGE, Mass., April 26, 2017 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced that it will host a live conference call and audio webcast at…
April 26, 2017 at 05:19PM
from
No comments:
Post a Comment